Ann: AGM Presentation, page-2

  1. 4,360 Posts.
    lightbulb Created with Sketch. 476
    "Over the last two years, Acrux has generated $20 million in revenue. The majority of this is revenue from our commercialised products."

    Are these guys taking the piss, or am I missing something?

    In both financial years ending June 2023 and June 2024 the business generated a sum total licencee fee 'revenue' of about $17.4m (ie operating revenue, ex of royalty divestments etc). But of this $14.7m were "pass though" expenses for cost-of-goods to the commercial partner (ie re-imbursement to Acrux of costs). No reasonable person would class this as "revenue".

    So in my book, that leaves revenue from commercialised product, in the two years, of about $2.7m. If we include the tax-payer funded generosity a la tax rebates, we can throw in an extra $6.3m, for a sum total of $8.9m. So of revenues that could be classed as "normal operating", about 70% are tax rebates.

    Hello? Can someone please tell me I'm getting something wrong!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.0¢
Change
0.000(0.00%)
Mkt cap ! $8.155M
Open High Low Value Volume
2.0¢ 2.0¢ 2.0¢ $12.32K 616.1K

Buyers (Bids)

No. Vol. Price($)
3 425000 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 276349 1
View Market Depth
Last trade - 10.02am 18/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.